Cedars-Science

March
21,
2023
| 09:00 AM America/Los_Angeles
When pharmacy staff develop an accurate medication list for high-risk patients being admitted to a hospital, medication errors—that could have led to substantial complications or even death—are significantly reduced, according to a new study led by
March
16,
2023
| 07:00 AM America/Los_Angeles
Cedars-Sinai has established a new Human Microbiome Research Institute that will support investigators studying how the microbiome, the diverse collection of bacteria, fungi and viruses that live in and on the human body, plays a role in
March
13,
2023
| 07:00 AM America/Los_Angeles
Alberto Ayala-Sarmiento, PhD, a postdoctoral scientist in the Breunig Lab, is focusing primarily on tumor modeling through genetic engineering and the development of new transgenesis tools. Ayala-Sarmiento was one of three Cedars-Sinai postdocs who
March
09,
2023
| 07:00 AM America/Los_Angeles
RESOURCESHigh Risk for Hypoglycemia Guideline Resources Ask the Expert: A Patient Approach to Preventing Hypoglycemia: A Conversation with Roma Gianchandani, MD 
March
07,
2023
| 07:00 AM America/Los_Angeles
Alessandra Ciullo, PhD, who is investigating how certain molecules repair the heart after a heart attack, and Zhongzheng Fu, PhD, whose work helps explain how people learn from mistakes, are the recipients of this year’s Cedars-Sinai Bohdan (Danny)
March
01,
2023
| 07:00 AM America/Los_Angeles
Cardiac electrophysiologist Eric Braunstein, MD, who joined the Smidt Heart Institute at Cedars-Sinai late last year, recently published a first-of-its kind case study in the peer-reviewed medical journal Heart Rhythm Case Reports. The case study
February
24,
2023
| 07:00 AM America/Los_Angeles
Cedars-Sinai is the coordinating center for the newly launched Southern California Cystic Fibrosis Research Program. The program will support research into personalized treatments, with an emphasis on identifying unique cystic fibrosis mutations in
February
23,
2023
| 07:00 AM America/Los_Angeles
Cedars-Sinai’s Efforts to Combat Lower Back Pain Get $2 Million Boost From CIRMInvestigators at Cedars-Sinai have received a $2 million grant from the California Institute for Regenerative Medicine (CIRM) to develop a new cell therapy that
February
21,
2023
| 07:00 AM America/Los_Angeles
Snigdha Bhowmick, PhD, is a postdoc in the laboratory of Neil Bhowmick, PhD, professor of Medicine and Biomedical Sciences at Cedars-Sinai. Her interest lies in studying the communication between tumor cells and microenvironment in liver